EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

EyePoint (EYPT) shares soared 15.2% in the last trading session to close at $14.91. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 14.2% loss over the past four weeks.EyePoint Pharmaceuticals’ pricesurge is likely tied to the company’s positive developments surrounding its lead candidate, Duravyu. Investor enthusiasm was driven by encouraging clinical progress, particularly around late-stage trial safety and advancement mileston ...